Original Article

Evaluation of the Effect of Acquisition Time on Image Quality of Adrenal Carcinoma PET/CT Scans

Abstract

Purpose: Adrenal adenomas are best detected and understood using a Positron Emission Tomography/Computed Tomography (PET/CT) scanner. When doing PET scans, the acquisition time of 18-Fluorodeoxyglucose (18FDG) absorption is crucial as it determines the diagnostic accuracy and quality of the images. This study aimed to investigate the effects of various acquisition periods to assess the efficacy of PET/CT in identifying adrenal adenomas (1.5 vs. 3 minutes).
Materials and Methods: The research included 30 patients who were thought to have adrenal adenomas. Following the 18FDG injection, PET/CT imaging was performed on each patient using one of two distinct acquisition times: 1.5 or 3 minutes. The image quality was objectively evaluated using a 5-point Likert scale. Experienced nuclear medicine professionals used consensus reading to assess diagnostic performance for adrenal adenoma identification.
Results: The preliminary findings showed that compared to the 1.5-minute acquisition technique, PET/CT imaging with a 3-minute duration after 18FDG injection produced considerably superior image quality (p < 0.05). In addition, the longer acquisition time significantly increased the chance of detecting the lesion more precisely, improving the visualisation and characterisation of adrenal adenomas. With greater sensitivity and specificity, the 3-minute acquisition methodology showed better diagnostic accuracy for adrenal adenoma identification than the 1.5-minute approach.
Conclusion: The study suggests that extending the acquisition time to 3 minutes improves image quality and diagnostic performance for adrenal adenoma detection, potentially improving patient care by facilitating accurate diagnosis and treatment planning.

1- Tarallo M, Crocetti D, Fiori E, Sapienza P, Letizia C, De Toma G, et al. "Criticism of the learning curve in laparoscopic adrenalectomy: A systematic review." Vol. 171, Clinica Terapeutica, (2020).
2- Ungureanu S, Şipitco N, Alexa Z, Gonţa V, Bujac M, Parnov M, et al. "MEN 2A syndrome – Multiple endocrine neoplasia with autosomal dominant transmission." Int J Surg Case Rep;73, (2020).
3- Pedullà G, Crocetti D, Paliotta A, Tarallo MR, De Gori A, Cavallaro G, et al. "Surgical treatment of pheochromocytoma in MEN 2." Ann Ital Chir.;85(5), (2014).
4- Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C. "Adrenal Lesions: Spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging." J Clin Imaging Sci, 3(1), (2013).
5- Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, et al. "Overview of the 2022 WHO Classification of Adrenal Cortical Tumors." Vol. 33, Endocrine Pathology, (2022).
6- Gunna S, Neyaz Z, Bhatia E, Marak RS, Mishra R, Verma R. "Results of percutaneous computed tomography-guided biopsy of adrenal lesions and spectrum of computed tomography findings." J Clin Imaging Sci.;10(1), (2020).
7- Caoili EM, Korobkin M, Brown RKJ, Mackie G, Shulkin BL. "Differentiating adrenal adenomas from non-adenomas using 18F-FDG PET/CT: quantitative and qualitative evaluation." Acad Radiol.;14(4):468–75, (2007).
8- Sahdev A. "Imaging incidental adrenal lesions." Br J Radiol [Internet]. 20;96(1141):202–18, (2022) Available at: https://doi.org/10.1259/bjr.20220281
9- Abdel Razek AAK, Sadek AG, Kombar OR, Elmahdy TE, Nada N. "Role of apparent diffusion coefficient values in differentiation between malignant and benign solitary thyroid nodules." American Journal of Neuroradiology;29(3), (2008).
10- Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, et al. "Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients with Non-Small Cell Lung Cancer." Clin Nucl Med.;34(4), (2009).
11- Lan XL, Zhang YX, Wu ZJ, Jia Q, Wei H, Gao ZR. The value of dual time point 18F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol. (2008);63(7).
12- Arena V, Skanjeti A, Casoni R, Douroukas A, Pelosi E. "Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake." Radiol Med.;113(6), (2008).
13- Tokariev M, Vuontela V, Perkola J, Lönnberg P, Lano A, Andersson S, et al. "A protocol for the analysis of DTI data collected from young children." Methods X.;7, (2020).
14- Beyer T, Antoch G, Müller S, Egelhof T, Freudenberg LS, Debatin J, et al. "Acquisition protocol considerations for combined PET/CT imaging." Vol. 45 Suppl 1, Journal of Nuclear Medicine : official publication, Society of Nuclear Medicine, (2004).
15- Jones T, Townsend D. "History and future technical innovation in positron emission tomography." Journal of Medical Imaging.;4(1), (2017).
16- Hausmann D, Dinter DJ, Sadick M, Brade J, Schoenberg SO, Büsing K. "The impact of acquisition time on image quality in whole-body 18F-FDG PET/CT for cancer staging." J Nucl Med Technol.;40(4), (2012).
17- Brown C, Dempsey MF, Gillen G, Elliott AT. "Investigation of 18F-FDG 3D mode PET image quality versus acquisition time." Nucl Med Commun.;31(3), (2010).
18- Goethals I, D’Asseler Y, Dobbeleir A, Deblaere K, Ham H. "The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer." Nucl Med Commun.;31(3), (2010).
19- Farquhar TH, Llacer J, Sayre J, Tai YC, Hoffman EJ. "ROC and LROC analyses of the effects of lesion contrast, size, and signal-to-noise ratio on detectability in PET images." Journal of Nuclear Medicine.;41(4), (2000)
20- Goethals I, D’Asseler Y, Dobbeleir A, Deblaere K, Ham H. "The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer." Nucl Med Commun.;31(3), (2010).
21- Alqahtani MM, Willowson KP, Constable C, Fulton R, Kench PL. "Optimisation of 99mTc whole-body SPECT/CT image quality: A phantom study." J Appl Clin Med Phys.;23(4), (2022).
22- Akin EA, Washington G. "Optimizing Oncologic FDG-PET/CT Scans to Decrease Radiation Exposure." Image Wisely: Radiation Safety in Adult Medical Imaging. (2017).
23- He Y, Gu Y, Yu H, Wu B, Wang S, Tan H, et al. "Optimising acquisition times for total-body positron emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients." EJNMMI Phys.;9(1), (2022).
24- Toya R, Matsuyama T, Saito T, Imuta M, Shiraishi S, Fukugawa Y, et al. "Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: Reducing interobserver variation." J Radiat Res.;60(3), (2019)
25- Woo MJ, Lowe SC, Devane AM, Gimbel RW. "Intervention to Reduce Interobserver Variability in Computed Tomographic Measurement of Cancer Lesions Among Experienced Radiologists." Vol. 50, Current Problems in Diagnostic Radiology, (2021).
26- Rao JS, Festoff BW, Baker JB, Morantz RA, Kimler B, Evans R. "Serpin Inhibitors of Urokinase and Thrombin in Normal Rat Brain and the 9L Brain Tumor: Evidence for Elevated Expression of Protease Nexin I-like Inhibitor and a Novel Sodium Dodecyl Sulfate-activated Tumor Antithrombin." Cancer Res.;50(16), (1990).
Files
IssueVol 12 No 4 (2025) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/fbt.v12i4.19812
Keywords
Positron Emission Tomography/Computed Tomography Adrenal Cancer Acquisition Time Image Quality
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Al-Hameed H, Raad Salman Z, Kadhim Essa H, Ahmed Aldulaimy MI, Altaii HA. Evaluation of the Effect of Acquisition Time on Image Quality of Adrenal Carcinoma PET/CT Scans. Frontiers Biomed Technol. 2025;12(4):757-763.